Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review

Alzheimer’s disease (AD) remains the leading cause of dementia worldwide, and over the last several decades, the role of inflammation in the pathogenesis of this neurodegenerative disorder has been increasingly elucidated. The initiation of the acute inflammatory response is counterbalanced by an ac...

Full description

Bibliographic Details
Main Authors: Robert A. Whittington, Emmanuel Planel, Niccolò Terrando
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-11-01
Series:Frontiers in Immunology
Subjects:
tau
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2017.01464/full
id doaj-b1fe7ec2a51c43b7a24f67305130cdd3
record_format Article
spelling doaj-b1fe7ec2a51c43b7a24f67305130cdd32020-11-24T22:25:50ZengFrontiers Media S.A.Frontiers in Immunology1664-32242017-11-01810.3389/fimmu.2017.01464298693Impaired Resolution of Inflammation in Alzheimer’s Disease: A ReviewRobert A. Whittington0Emmanuel Planel1Emmanuel Planel2Niccolò Terrando3Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, NY, United StatesFaculté de Médecine, Département de Psychiatrie et Neurosciences, Université Laval, Québec City, QC, CanadaCentre de Recherche du CHU de Quebec, Centre Hospitalier de l’Université Laval, Neurosciences, Québec City, QC, CanadaDepartment of Anesthesiology, Duke University, Durham, NC, United StatesAlzheimer’s disease (AD) remains the leading cause of dementia worldwide, and over the last several decades, the role of inflammation in the pathogenesis of this neurodegenerative disorder has been increasingly elucidated. The initiation of the acute inflammatory response is counterbalanced by an active process termed resolution. This process is designed to restore homeostasis and promote tissue healing by the activation of neutrophilic apoptosis, promotion of neutrophil clearance by macrophages, and increasing anti-inflammatory cytokine levels, while concurrently leading to a diminution in pro-inflammatory mediators. The switch from the initiation to the resolution phase of inflammation is initially characterized by increased production of arachidonic acid-derived pro-resolving lipoxins and decreases in pro-inflammatory prostaglandin and leukotriene levels, subsequently followed by increases in specialized pro-resolving lipid mediators derived from omega-3 fatty acids (ω-3 FAs). There is mounting evidence that in AD, the resolution of inflammation is impaired, resulting in chronic inflammation and the exacerbation of the AD-related pathology. In this review, we examine preclinical and clinical evidence supporting the hypothesis that AD is a neurodegenerative disorder where the impairment or failure of resolution contributes to the disease process. Moreover, we review the literature supporting the potential therapeutic role of ω-3 FAs and specialized pro-resolving lipid mediators in the management of the disease. Lastly, we highlight areas that could strengthen the association of failed resolution to AD and should, therefore, be the focus of future scientific investigations in this research field.http://journal.frontiersin.org/article/10.3389/fimmu.2017.01464/fullAlzheimer’s diseaseresolutioninflammationbeta-amyloidtauresolvins
collection DOAJ
language English
format Article
sources DOAJ
author Robert A. Whittington
Emmanuel Planel
Emmanuel Planel
Niccolò Terrando
spellingShingle Robert A. Whittington
Emmanuel Planel
Emmanuel Planel
Niccolò Terrando
Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review
Frontiers in Immunology
Alzheimer’s disease
resolution
inflammation
beta-amyloid
tau
resolvins
author_facet Robert A. Whittington
Emmanuel Planel
Emmanuel Planel
Niccolò Terrando
author_sort Robert A. Whittington
title Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review
title_short Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review
title_full Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review
title_fullStr Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review
title_full_unstemmed Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review
title_sort impaired resolution of inflammation in alzheimer’s disease: a review
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2017-11-01
description Alzheimer’s disease (AD) remains the leading cause of dementia worldwide, and over the last several decades, the role of inflammation in the pathogenesis of this neurodegenerative disorder has been increasingly elucidated. The initiation of the acute inflammatory response is counterbalanced by an active process termed resolution. This process is designed to restore homeostasis and promote tissue healing by the activation of neutrophilic apoptosis, promotion of neutrophil clearance by macrophages, and increasing anti-inflammatory cytokine levels, while concurrently leading to a diminution in pro-inflammatory mediators. The switch from the initiation to the resolution phase of inflammation is initially characterized by increased production of arachidonic acid-derived pro-resolving lipoxins and decreases in pro-inflammatory prostaglandin and leukotriene levels, subsequently followed by increases in specialized pro-resolving lipid mediators derived from omega-3 fatty acids (ω-3 FAs). There is mounting evidence that in AD, the resolution of inflammation is impaired, resulting in chronic inflammation and the exacerbation of the AD-related pathology. In this review, we examine preclinical and clinical evidence supporting the hypothesis that AD is a neurodegenerative disorder where the impairment or failure of resolution contributes to the disease process. Moreover, we review the literature supporting the potential therapeutic role of ω-3 FAs and specialized pro-resolving lipid mediators in the management of the disease. Lastly, we highlight areas that could strengthen the association of failed resolution to AD and should, therefore, be the focus of future scientific investigations in this research field.
topic Alzheimer’s disease
resolution
inflammation
beta-amyloid
tau
resolvins
url http://journal.frontiersin.org/article/10.3389/fimmu.2017.01464/full
work_keys_str_mv AT robertawhittington impairedresolutionofinflammationinalzheimersdiseaseareview
AT emmanuelplanel impairedresolutionofinflammationinalzheimersdiseaseareview
AT emmanuelplanel impairedresolutionofinflammationinalzheimersdiseaseareview
AT niccoloterrando impairedresolutionofinflammationinalzheimersdiseaseareview
_version_ 1725756080154214400